Publication | Open Access
Huntington’s disease onset is determined by length of uninterrupted CAG, not encoded polyglutamine, and is modified by DNA maintenance mechanisms
11
Citations
62
References
2019
Year
Unknown Venue
GeneticsGenetic EpidemiologyMolecular BiologyDisease OnsetMolecular GeneticsDisease Gene IdentificationClinical GeneticsHd PathogenesisDegenerative PathologyDna Maintenance MechanismsVariant InterpretationMonogenic DisordersGenome InstabilityLength InstabilityInherited Metabolic DiseaseDna ReplicationNeurodegenerationEpigenetic RegulationNeurodegenerative DiseasesHuntington ’Molecular MechanismsNatural SciencesGenetic DisorderPolymorphic VariationDegenerative DiseaseMedical GeneticsSystems BiologyMedicineCell Development
SUMMARY The effects of variable, glutamine-encoding, CAA interruptions indicate that a property of the uninterrupted HTT CAG repeat sequence, distinct from huntingtin’s polyglutamine segment, dictates the rate at which HD develops. The timing of onset shows no significant association with HTT cis -eQTLs but is influenced, sometimes in a sex-specific manner, by polymorphic variation at multiple DNA maintenance genes, suggesting that the special onset-determining property of the uninterrupted CAG repeat is a propensity for length instability that leads to its somatic expansion. Additional naturally-occurring genetic modifier loci, defined by GWAS, may influence HD pathogenesis through other mechanisms. These findings have profound implications for the pathogenesis of HD and other repeat diseases and question a fundamental premise of the “polyglutamine disorders”.
| Year | Citations | |
|---|---|---|
Page 1
Page 1